Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs16902094
rs16902094
G 0.720 GeneticVariation GWASCAT Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. 19767754

2009

dbSNP: rs16902094
rs16902094
0.720 GeneticVariation BEFREE These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01). 25315430

2014

dbSNP: rs16902094
rs16902094
0.720 GeneticVariation BEFREE A statistically significant interaction was observed for each of 2 SNPs in the 8q24 region (rs620861 and rs16902094), 25(OH)D concentration, and fatal prostate cancer on both multiplicative and additive scales (P ≤ 0.001). 28399564

2017

dbSNP: rs445114
rs445114
T 0.700 GeneticVariation GWASCAT Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. 19767754

2009

dbSNP: rs445114
rs445114
T 0.700 GeneticVariation GWASCAT Genome-wide association study identifies new prostate cancer susceptibility loci. 21743057

2011

dbSNP: rs4506170
rs4506170
C 0.700 GeneticVariation GWASCAT Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21. 27262462

2016

dbSNP: rs378854
rs378854
0.010 GeneticVariation BEFREE This approach identified rs378854, which is in complete linkage disequilibrium (LD) with rs620861, as a novel functional prostate cancer-specific genetic variant. 21814516

2011

dbSNP: rs72725854
rs72725854
T 0.710 GeneticVariation GWASCAT The 8q24 risk region was also found to be a major contributor to PCa risk in Ugandan men, with the African ancestry-specific risk variant rs72725854 estimated to account for 12% of PCa in this population. 29356057

2018

dbSNP: rs72725854
rs72725854
0.710 GeneticVariation BEFREE The 8q24 risk region was also found to be a major contributor to PCa risk in Ugandan men, with the African ancestry-specific risk variant rs72725854 estimated to account for 12% of PCa in this population. 29356057

2018

dbSNP: rs1456314
rs1456314
G 0.700 GeneticVariation GWASCAT Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. 17401366

2007

dbSNP: rs17831626
rs17831626
T 0.700 GeneticVariation GWASCAT Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. 17401366

2007

dbSNP: rs6993569
rs6993569
G 0.700 GeneticVariation GWASCAT Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. 17401366

2007

dbSNP: rs77541621
rs77541621
A 0.700 GeneticVariation GWASCAT A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. 26034056

2015

dbSNP: rs7825414
rs7825414
G 0.700 GeneticVariation GWASCAT Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. 17401366

2007

dbSNP: rs16901979
rs16901979
0.800 GeneticVariation BEFREE Significant differences (P < 0.00185) between the two subtypes were observed for rs16901979 (8q24) and rs1859962 (17q24), which were enriched in TMPRSS2:ERG fusion-negative (OR = 0.53, P = 0.0007) and TMPRSS2:ERG fusion-positive PrCa (OR = 1.30, P = 0.0016), respectively. 27798103

2016

dbSNP: rs16901979
rs16901979
0.800 GeneticVariation BEFREE There was no joint effect between SNPs rs16901979 A and rs6983267 G. These results confirm the significance of these SNPs in prostate cancer etiology in a previously unstudied population who do not undergo prostate cancer screening and are diagnosed with severe disease. 18768513

2008

dbSNP: rs16901979
rs16901979
0.800 GeneticVariation BEFREE Forty-nine tagging SNPs including three previously reported significant variants (rs1447295, rs6983267, rs16901979) and seven variants in the 5' upstream region of the MYC proto-oncogene were tested for association with susceptibility to PC and tumor aggressiveness in 596 histologically verified PC cases and 567 ethnically matched controls. 19562729

2009

dbSNP: rs16901979
rs16901979
0.800 GeneticVariation BEFREE In particular, both homozygous AA and heterozygous CA genotypes of rs16901979, as well as the AA and CA genotypes of rs1447295, were associated with the risk of prostate cancer. 30061842

2018

dbSNP: rs16901979
rs16901979
0.800 GeneticVariation BEFREE A meta-analysis across 10 studies including our results of four 8q24 variants (rs1442295 and DG8S737-region 1, rs16901979-region 2, and rs6983267-region 3) and prostate cancer risk demonstrated strong associations across a wide array of study designs and populations. 18231127

2008

dbSNP: rs16901979
rs16901979
0.800 GeneticVariation BEFREE The results of the meta-analyses indicate that rs6983267, rs1447295, rs6983561, rs7837688, rs16901979, and DG8S737 are significantly associated with a higher risk for PCa for at least one race, whereas the variants rs13254738 and rs7000448 are not. 22382457

2012

dbSNP: rs16901979
rs16901979
0.800 GeneticVariation BEFREE In summary, the A allele at rs16901979 was associated with the risk of prostate cancer in the Caribbean population of Guadeloupe, confirming its involvement in populations of African descent. 25130587

2016

dbSNP: rs16901979
rs16901979
A 0.800 GeneticVariation GWASCAT Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. 17401366

2007

dbSNP: rs16901979
rs16901979
0.800 GeneticVariation BEFREE Two of these 17 SNPs, located at 3p12, and region 2 at 8q24, were significantly associated with prostate cancer risk (P < 0.05), and only SNP rs16901979 at region 2 of 8q24 remained significant after accounting for 20 tests. 19549807

2009

dbSNP: rs16901979
rs16901979
A 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019

dbSNP: rs16901979
rs16901979
0.800 GeneticVariation BEFREE SNPs rs6983561, rs7008482, and rs16901979 were significantly associated with CaP risk in WAs (P < 0.03). 22234922

2012